The human-induced pluripotent stem cell initiative-data resources for cellular genetics
Ian Streeter1, Peter W Harrison1, Adam Faulconbridge1
1European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Nucleic Acids Research
|October 14, 2016
Summary
The Human Induced Pluripotent Stem Cell Initiative (HipSci) provides a comprehensive catalog of well-characterized human induced pluripotent stem cell (iPSC) lines and associated multi-omics data. This resource facilitates cell line selection and data reuse for research.
Area of Science:
- Stem Cell Biology
- Genomics
- Bioinformatics
Background:
- The Human Induced Pluripotent Stem Cell Initiative (HipSci) is building a large, well-characterized collection of human induced pluripotent stem cell (iPSC) lines.
- Existing resources often lack comprehensive multi-omics data or easy accessibility for researchers.
Purpose of the Study:
- To establish and characterize a substantial collection of human iPSC lines for research purposes.
- To create a user-friendly portal for discovering, selecting, and reusing iPSC lines and their associated assay data.
- To deposit data in public EMBL-EBI archives for broad accessibility.
Main Methods:
- Generation and characterization of human iPSC lines from healthy individuals and patients with rare genetic diseases.
- Comprehensive data generation including genomic, transcriptomic, proteomic, and cellular phenotyping assays.
- Data deposition into EMBL-EBI archives (ENA, EGA, ArrayExpress, PRIDE) and presentation via the HipSci data portal.
- Development of a Track Hub for visualizing analysis results alongside public genomic annotations.
Main Results:
- As of August 2016, 238 iPSC lines are available, with a goal of 500 lines from healthy donors and 150 from patients.
- The HipSci portal provides a summary matrix of cell lines and data types, with individual pages detailing metadata, quality, and links to archived data.
- Data is accessible through the HipSci portal and FTP site, with analysis results available in a Track Hub for genomic context visualization.
Conclusions:
- The HipSci initiative provides an invaluable, well-characterized resource of human iPSC lines and multi-omics data.
- The data portal and associated archives enhance data discoverability, accessibility, and reusability for the scientific community.
- This resource supports research in stem cell biology, regenerative medicine, and disease modeling.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
5.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.9K
Induced Pluripotent Stem Cells
4.0K
4.0K
Induced Pluripotent Stem Cells
28.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.4K
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K


